- Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Enovis Announces Fourth Quarter and Full Year 2023 Results
- Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
- Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
- Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
- Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
- Enovis Introduces the DonJoy ROAM™ OA Knee Brace
- Enovis 完成对 LimaCorporate S.p.A 的收购
- Enovis 完成對 LimaCorporate S.p.A 的收購
- エノビス (Enovis) がリマ・コーポレート (LimaCorporate S.p.A) の買収を完了
More ▼
Key statistics
As of last trade Enovis Corp (C520:MUN) traded at 57.00, -2.56% below its 52-week high of 58.50, set on Feb 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 57.00 |
---|---|
High | 57.00 |
Low | 57.00 |
Bid | 57.50 |
Offer | 58.00 |
Previous close | 55.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 54.62m |
Free float | 49.60m |
P/E (TTM) | -- |
Market cap | 3.41bn USD |
EPS (TTM) | -0.9987 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 07:05 BST.
More ▼